References
- Abdalla M, El-Arabey AA, Jiang X. Are the new SARS-CoV-2 variants resistant against the vaccine? Hum Vaccin Immunother. 2021;1–2. doi:10.1080/21645515.2021.1925503.
- Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854):438–43. doi:10.1038/s41586-021-03402-9.
- Jones TC, Biele G, Muhlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, Bleicker T, Tesch J, Schmidt ML, Sander LE, et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373(6551):eabi5273. doi:10.1126/science.abi5273.
- Ferreira I, Datir R, Kemp S, Papa G, Rakshit P, Singh S, et al. SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies. bioRxiv: Preprint Ser Biol. 2021. doi:10.1101/2021.05.08.443253.
- Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, Rangarajan ES, Pan A, Vanderheiden A, Suthar MS, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020;11;6013. doi:10.1038/s41467-020-19808-4
- Tchesnokova V, Kulakesara H, Larson L, Bowers V, Rechkina E, Kisiela D, Sledneva Y, Choudhury D, Maslova I, Deng K, et al. Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants. bioRxiv [Preprint]. 2021 Mar 11. doi: 10.1101/2021.02.22.432189. PMID: 33758861; PMCID: PMC7987020.
- Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi:10.1126/science.abg3055.
- Di Giacomo S, Mercatelli D, Rakhimov A, Giorgi FM. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K. J Med Virol. 2021;93(9):5638–43. doi:10.1002/jmv.27062.
- Cele S, Gazy I, Jackson L, Hwa SH, Tegally H, Lustig G, Giandhari J, Pillay S, Wilkinson E, Naidoo Y, et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature. 2021;593(7857):142–46. doi:10.1038/s41586-021-03471-w.
- Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, Lambson BE, de Oliveira T, Vermeulen M, Van Der Berg K, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021;27(4):622–25. doi:10.1038/s41591-021-01285-x.
- Saito A, Nasser H, Uriu K, Kosugi Y, Irie T, Shirakawa K, et al. SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion. bioRxiv: Preprint Ser Biol. 2021; doi:10.1101/2021.06.17.448820.
- Wang P, Casner RG, Nair MS, Wang M, Yu J, Cerutti G, Liu L, Kwong PD, Huang Y, Shapiro L, et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe. 2021;29(5):747–51 e4. doi:10.1016/j.chom.2021.04.007.
- Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. N Engl J Med. 2021;385:585–594. doi: 10.1056/NEJMoa2108891.
- Murin CD, Wilson IA, Ward AB. Antibody responses to viral infections: a structural perspective across three different enveloped viruses. Nat Microbiol. 2019;4:734–47. doi:10.1038/s41564-019-0392-y.
- Zhang Y, Chirmule N, Gao GP, Qian R, Croyle M, Joshi B, Tazelaar J, Wilson JM. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther. 2001;3:697–707. doi:10.1006/mthe.2001.0329.
- Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–27 e19. doi:10.1016/j.cell.2020.06.043.
- Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592(7852):116–21. doi:10.1038/s41586-020-2895-3.
- Yuan M, Wu NC, Zhu X, Lee CD, So RTY, Lv H, Mok CKP, Wilson IA. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368(6491):630–33. doi:10.1126/science.abb7269.
- Hoffmann M, Kleine-Weber H, Pohlmann S, Multibasic Cleavage A. Site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78:779–84 e5. doi:10.1016/j.molcel.2020.04.022.
- Shokeen K, Pandey S, Shah M, Kumar S. Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases. bioRxiv: Preprint Ser Biol. 2020.04.25.061507. 2020. doi:10.1101/2020.04.25.061507
- Davis N. The covid delta variant: how effective are the vaccines? In: Davis N editor. The Guardian. Interantional edition; 2021. https://www.theguardian.com/world/2021/jun/15/the-covid-delta-variant-how-effective-are-the-vaccines.
- Catherine S-B How well COVID-19 vaccines work against the Delta variant, according to the best available data. Business insider. India; 2021:https://www.businessinsider.in/science/health/news/how-well-covid-19-vaccines-protect-against-the-delta-variant-according-to-the-best-available-data/articleshow/84233954.cms.